BrainBalance
Minimally Invasive Device for the Treatment of Alzheimer's Disease
Company Overview
Snapshot
Founded in June 2016, BrainBalance operates with a team of 1-10 employees. The company is currently in the Pre-Funding stage, focusing on the development of its core technology.
Business overview
BrainBalance is a Health Tech & Life Sciences company specializing in medical devices and medical treatment & therapeutics. The company is developing a minimally invasive device designed to treat Alzheimer's disease. Its core technology utilizes a directional electrical field to enhance the natural clearance of amyloid-beta from brain parenchyma to the cerebrospinal fluid, aiming to restore homeostasis in the extracellular environment and halt disease progression. BrainBalance primarily serves the healthcare sector, targeting providers with its B2C business model.
Log in to access full profile ›Company Intelligence Q&A
- What is BrainBalance's primary focus?
- BrainBalance is focused on developing a minimally invasive device for the treatment of Alzheimer's disease.
- When was BrainBalance founded?
- BrainBalance was founded in June 2016.
- What is the core technology behind BrainBalance's solution?
- BrainBalance's technology uses a directional electrical field to enhance the natural clearance of amyloid-beta from brain parenchyma to the cerebrospinal fluid, aiming to restore homeostasis and halt disease progression.
- In which sector does BrainBalance primarily operate?
- BrainBalance operates primarily in the Health Tech & Life Sciences sector, specifically within Medical Devices and Medical Treatment & Therapeutics.
- What is the current product stage of BrainBalance's technology?
- BrainBalance's product is currently in the R&D stage, as of its last update in December 2020, focusing on developing a minimally invasive device for Alzheimer's disease.